×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TSHA – taysha gene therapies, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TSHA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
09:34 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $6.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $6.00 to $8.00. They now have a "buy" rating on the stock.
11/14
06:30 pm
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
Medium
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
11/14
02:31 am
tsha
Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ... [Yahoo! Finance]
High
Report
Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ... [Yahoo! Finance]
11/13
10:50 pm
tsha
Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript [Seeking Alpha]
High
Report
Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript [Seeking Alpha]
11/13
07:22 pm
tsha
Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
High
Report
Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/13
04:01 pm
tsha
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/12
11:07 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
High
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
11/12
09:03 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
High
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
04:01 pm
TSHA
taysha gene therapies, inc.
MISS
Report
2.7%
taysha gene therapies, inc.
8/12/2024
08:01 am
TSHA
taysha gene therapies, inc.
BEAT
Report
-4.7%
taysha gene therapies, inc.
5/14/2024
04:01 pm
TSHA
taysha gene therapies, inc.
BEAT
Report
18.7%
taysha gene therapies, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
11/12
11:07 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
High
Report
11.2%
11/12
11:07 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
High
Report
11.2%
Date
Time
Symbol
Headline
Impact
11/14
05:51 pm
tsha
Form SC 13G/A Taysha Gene Therapies, Filed by: Venrock Healthcare Capital Partners III, L.P.
Medium
Report
Form SC 13G/A Taysha Gene Therapies, Filed by: Venrock Healthcare Capital Partners III, L.P.
11/14
05:47 pm
tsha
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
09:41 am
tsha
Form SC 13G Taysha Gene Therapies, Filed by: Avoro Capital Advisors LLC
High
Report
Form SC 13G Taysha Gene Therapies, Filed by: Avoro Capital Advisors LLC
11/13
04:39 pm
tsha
Form 10-Q Taysha Gene Therapies, For: Sep 30
Medium
Report
Form 10-Q Taysha Gene Therapies, For: Sep 30
11/13
04:11 pm
tsha
Form 8-K Taysha Gene Therapies, For: Nov 13
Medium
Report
Form 8-K Taysha Gene Therapies, For: Nov 13
11/12
10:35 am
tsha
Form SC 13G/A Taysha Gene Therapies, Filed by: FMR LLC
High
Report
Form SC 13G/A Taysha Gene Therapies, Filed by: FMR LLC
11/8
02:19 pm
tsha
Form SC 13G Taysha Gene Therapies, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Taysha Gene Therapies, Filed by: BlackRock, Inc.
10/22
06:07 pm
tsha
Form SC 13G Taysha Gene Therapies, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Taysha Gene Therapies, Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: